BPC-157 (Acetate)
$18.70 – $63.75
BPC-157 vs TB-500: Research Comparison
Reference comparison for laboratory researchers. All material on this page is for in-vitro and investigational research only.
| BPC-157 | TB-500 | |
|---|---|---|
| Compound class | Synthetic pentadecapeptide | Synthetic thymosin beta-4 related peptide |
| Research focus | Regenerative tissue research | Wound healing / angiogenesis research |
| Relation to full-length protein | Distinct synthetic sequence | Related to, but not identical to, full-length thymosin beta-4 |
| Evidence base | Largely preclinical | Largely preclinical |
TB-500 (Thymosin B4 Acetate)
$24.00 – $68.00
Key Differences
- BPC-157 is a short synthetic pentadecapeptide; TB-500 is a fragment-related peptide studied as distinct from full-length thymosin beta-4.
- Most published data are preclinical (in-vitro / animal); this is an important limitation when comparing the two.
Evidence and Limitations
Preclinical research: both compounds appear in in-vitro and animal wound/repair studies.
Limitations: TB-500 is not the same molecule as full-length thymosin beta-4; extrapolating full-protein biology to the fragment is not justified. No established human clinical use is claimed here.
Research Notes
Browse the Healing & Repair category, or view batch documentation for BPC-157 (Acetate) and TB-500 (Thymosin B4 Acetate). All AminoForge material is supplied as a lyophilized research vial with an independently HPLC-verified batch record, for laboratory research use only.